SLIDE 1
Lung Cancer MDT Project BHRUT Lucy Gladman – General Manager
SLIDE 2 BHRUT
Large Acute Trust
–
Population ~ 750,000
Treat 10% of London's cancers; 50% of NEL’s cancers
Financially challenged
Special measures since January 2014
Lung MDT
1st April 2014 – 31st March 2015*
–
303 primary patients diagnosed
–
306 patients discussed at MDT
–
203 treatments
37 monitoring 44 chemo 6 chemo radiotherapy 39 palliative care 50 surgery 27 radiotherapy
Staging completeness Jan – Dec 2014 – 89%**
* Somerset, ** COSD
SLIDE 3 Project Objectives
To establish baseline metrics; To redesign and implement an MDT model that meets
the requirements of the London Cancer pathway specification;
To devise a plan for monitoring and evaluating the
effectiveness of the redesigned MDT;
To measure and evaluate the impact and effectiveness
- f the revised MDT model and ensure alignment with
national best practice;
To use the intelligence gained to develop a “blue print”
model and recommendations for wider implementation.
SLIDE 4
Project Support
Two partnered Trusts to pool expertise; Supported by Medical and Educational Grant
from Pfizer;
Project manager appointed from Quintiles; Lead Clinician for Cancer; Lung MDT Clinical Lead; Service Manager for Respiratory; General Manager for Cancer.
SLIDE 5 Baseline Data
Top priority KPIs:
–
Time from referral to DTT;
–
Number of patients who go on to treatment;
–
Number of patients who go on to be enrolled in clinical trials;
Additional KIPs
–
Number of new patients per MDT;
–
MDT attendance;
–
Time from referral to diagnosis;
–
Time from referral to staging;
–
Time from staging to DTT MDT;
–
Proportion of patients to:
Surgery Chemotherapy Palliative intervention.
SLIDE 6
Project Timeline
SLIDE 7
Workshop
7th January 2015; 23 attendees
– Physicians, Surgeon, CNS’s, MDT Coordinators,
Hisptopathologist, Oncologist, Palliative Care, Radiologist, Managers
17 high level actions identified; Three overarching themes:
MDT 2WW Surgery
SLIDE 8
Actions Identified
Excessive workload of the lung cancer MDT
and need for lung nodule MDT;
CT scan required prior to first OPA; Optimise days for EBUS; Increased lung function capacity required PET scanner needed; Communication between Trusts Improved data
SLIDE 9
Actions Implemented
Nodule MDT;
– Protocol written; – Budget identified for admin support; – Advertised and interviewed 27th May. – Start date TBA!
To pilot nurse-led nodule service;
– Business case to be developed
SLIDE 10
Actions Implemented
CT scan prior to first OPA; Previous implementation put 2ww target at
risk;
Audit undertaken of 2 weeks of 2ww referrals;
– Understand actual demand – Try to establish protocol for Cancer Referrals Office
Meeting held with radiology for them to
understand MDT requirement;
Need to identify area for CT hydration patients
SLIDE 11
Actions Implemented
Excessive workload of MDT; Audit undertaken of delayed patients due to
unavailability of notes at MDT;
Nodule MDT will move some workload; Inter-MDT process refined; EBUS moved to Wednesday;
– Reduces number of patients not discussed at MDT;
Review MDT Coordinator support;
– Pool work across site; – Band 3 support to coordinate MDT agenda
SLIDE 12
Actions Implemented
Enabling works for PET scanner;
– Awaiting financial approval;
Need business case to increase lung function
test capacity;
Meeting with Bart’s Health – 4th June 2015, to
improve communications;
MDT received training on how to improve data
quality for NLCA;
Review MDT once all actions implemented.
SLIDE 13
Summary
Identified short, medium and long term actions; Brought team together; Focused the actions needed; Raised profile of cancer targets with the
clinicians;
Identified audits to be undertaken; Project overran;
– Restructure; – CQC re-visit
Committed to keeping up the actions.
SLIDE 14
“If there is no struggle, there is no progress.” Frederick Douglass